NCT03015259: A trial that was reported late by Kindeva Drug Delivery
This trial has reported, although it was 490 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03015259 |
|---|---|
| Title | Randomized, Single Blind, Parallel Group, Placebo Controlled, Multidose Study Comparing the Therapeutic Equivalence of a 3M Budesonide/Formoterol Fumarate Inhaler and a Symbicort® Reference Inhaler in Adult Subjects With Asthma |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 29, 2016 |
| Completion date | Feb. 8, 2018 |
| Required reporting date | Feb. 8, 2021, midnight |
| Actual reporting date | June 13, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 490 |